EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Transitions from combustible to noncombustible tobacco use and liver outcomes in steatotic liver disease

Eun Seok Kang, Su Kyoung Lee, Meng Sha, Stefano Romeo, Seogsong Jeong, Won Kim

Clinical and Molecular Hepatology · 01.10.2026 · 32 (4) · e2026.0339

DOI: 10.3350/cmh.2026.0339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2026. Verfasst von Eun Seok Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: In adults with steatotic liver disease (SLD), the hepatic impact of transitioning between combustible cigarettes (CCs) and noncombustible nicotine or tobacco products (NNTPs) remains unclear. We examined CC-NNTP transitions and liver-related events (LREs).

Methods

From the Korean National Health Insurance Service, 502,198 adults with SLD and at least one cardiometabolic risk factor completing health screenings during both 2012–2013 and 2019–2020 were followed through December 2023. Seven mutually exclusive groups were defined by CC status and NNTP use; the primary outcome was LRE, including hepatocellular carcinoma and liver cirrhosis. Cox proportional hazards regression, propensity-score matching (PSM), and counterfactual mediation analysis were performed.

Results

Among 502,198 participants (mean age 57.9 years; 65.6% male), 2,549 LREs occurred over a median 3.0-year follow-up. Compared with never-smokers, continuous CC smokers without NNTP use had the highest LRE risk (adjusted hazard ratio [aHR] 1.51; 95% confidence interval [CI] 1.34–1.70), followed by CC initiators (1.45; 1.17–1.79) and CC quitters (1.28; 1.12–1.46) without NNTPs. CC quitters with NNTP use showed a lower LRE risk than continuous CC smokers without NNTP use in the full cohort (aHR 0.65; 95% CI 0.43–0.99), but this association was not statistically significant under PSM (aHR 0.65; 95% CI 0.39–1.09). Within-group PSM of NNTP versus nonuse was nonsignificant across all CC categories.

Conclusions

CC cessation was associated with lower LRE risk than continued CC smoking, even among those who transitioned to NNTPs. However, NNTP use showed no independent protective association, supporting complete tobacco/nicotine abstinence as the preferred goal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverHumansMiddle AgedMaleFemaleLiver NeoplasmsProportional Hazards ModelsLiver CirrhosisAgedRisk FactorsCarcinoma, HepatocellularTobacco ProductsAdult

Stichwörter der Autor:innen

Carcinoma, hepatocellularElectronic nicotine delivery systemsLiver cirrhosisNonalcoholic fatty liver diseaseSmoking cessation

Autor:innen und Institutionen

  • Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea.
  • Department of Healthcare Management, College of Health and Medical Science, Daejeon University, Daejeon, Korea.
  • Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • CeRM at Karolinska Institute and Endocrinology Department at Karolinska Hospital, Huddinge, Sweden. stefano.romeo@ki.se.
  • Department of Medical and Surgical Sciences, Clinical Nutrition Unit, Magna Graecia University, Germaneto, Italy. stefano.romeo@ki.se.
  • Institute of Medicine, Gothenburg University and Cardiology Department Sahlgrenska Hospital, Gothenburg Sweden. stefano.romeo@ki.se.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Kang, E. S., Lee, S. K., Sha, M., Romeo, S., Jeong, S., & Kim, W. (2026). Transitions from combustible to noncombustible tobacco use and liver outcomes in steatotic liver disease. Clinical and Molecular Hepatology, 32(4), e2026.0339. https://doi.org/10.3350/cmh.2026.0339

Vancouver

Kang ES, Lee SK, Sha M, Romeo S, Jeong S, Kim W. Transitions from combustible to noncombustible tobacco use and liver outcomes in steatotic liver disease. Clinical and Molecular Hepatology. 2026;32(4):e2026.0339. doi:10.3350/cmh.2026.0339

BibTeX
@article{Kang2026,
  author = {Kang, Eun Seok and Lee, Su Kyoung and Sha, Meng and Romeo, Stefano and Jeong, Seogsong and Kim, Won},
  title = {Transitions from combustible to noncombustible tobacco use and liver outcomes in steatotic liver disease},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {e2026.0339},
  doi = {10.3350/cmh.2026.0339}
}
Kostenlos starten →